Prescription drugs

July 11, 2019 - 11:58 am
LONDON (AP) — Consumer products company Reckitt Benckiser says it will pay $1.4 billion to resolve U.S. investigations into the marketing of an anti-addiction drug by a subsidiary. The company said Thursday it reached agreements with the U.S. Department of Justice and the Federal Trade Commission...
Read More
President Donald Trump speaks about kidney health at the Ronald Reagan Building and International Trade Center, accompanied by Health and Human Services Secretary Alex Azar, left, Wednesday, July 10, 2019, in Washington. (AP Photo/Alex Brandon)
July 11, 2019 - 10:33 am
WASHINGTON (AP) — President Donald Trump is withdrawing a plan to ease the financial bite of costly medications for people on Medicare by letting them to receive rebates that drugmakers now pay to insurers and middlemen, the White House said Thursday. The once-highly promoted plan from Health and...
Read More
FILE - In this Oct. 25, 2018, file photo, President Donald Trump talks about drug prices during a visit to the Department of Health and Human Services in Washington. A federal judge Monday, July 8, 2019, blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads. (AP Photo/Susan Walsh, File)
July 08, 2019 - 10:51 pm
WASHINGTON (AP) — A federal judge Monday blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads. The narrow ruling by U.S. District Judge Amit Mehta in Washington, D.C.,...
Read More
In this June 20, 2019 photo, the Capitol is seen from the roof of the Canadian Embassy in Washington. Health care is on the agenda for Congress when lawmakers return, and it’s not another battle over the Obama-era Affordable Care Act. Instead of dealing with the uninsured, lawmakers are trying to bring down costs for people who already have coverage. (AP Photo/J. Scott Applewhite)
July 07, 2019 - 9:00 am
WASHINGTON (AP) — Lawmakers are trying to set aside their irreconcilable differences over the Obama-era Affordable Care Act and work to reach bipartisan agreement on a more immediate health care issue, lowering costs for people who already have coverage. Returning from their Fourth of July recess,...
Read More
President Donald Trump talks to reporters on the South Lawn of the White House before departing for his Bedminster, N.J. golf club, Friday, July 5, 2019, in Washington. (AP Photo/Evan Vucci)
July 05, 2019 - 1:04 pm
WASHINGTON (AP) — President Donald Trump is promising an executive order that he says is intended to enable the U.S. government to pay lower prices for prescription drugs. Trump says his administration soon would announce a "favored-nations clause," where the amount paid by the government for a...
Read More
June 25, 2019 - 9:17 am
CLEVELAND (AP) — Tension is emerging between lawyers representing state and local governments over the path forward in a set of lawsuits seeking to hold the drug industry accountable for the toll of the nation's opioid crisis. A federal judge is holding a hearing Tuesday in Cleveland on a plan...
Read More
FILE - In this Aug. 17, 2018 file photo, family and friends who lost loved ones to opioid overdoses protest outside the headquarters of Purdue Pharma, maker of the maker of painkiller OxyContin, in Stamford, Conn. The World Health Organization notified U.S. lawmakers Wednesday, June 19, 2019, that it will discontinue two publications on opioid painkiller prescribing, in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines - viewed around the world as best practices in public health - comes a month after U.S. Reps. Katherine Clark and Hal Rogers accused the WHO of being influenced by Purdue. The lawmakers’ report claimed the guidelines were crafted by organizations with financial ties to the company, who worked to downplay risks addiction and overstate the benefits of opioids. Purdue has denied the allegations. (AP Photo/Jessica Hill, File)
June 19, 2019 - 11:24 pm
The World Health Organization notified U.S. lawmakers Wednesday that it will discontinue two publications on prescribing opioid painkillers in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines comes a month after U.S. Reps...
Read More
Rep. Anna Eshoo, D-Calif., right, chair of the House Health Subcommittee, says President Donald Trump and Attorney General William Barr want to take a sledgehammer to health care, as she joins, from left, Rep. Lisa Blunt Rochester, D-Del., House Speaker Nancy Pelosi, D-Calif., and Senate Minority Leader Chuck Schumer, D-N.Y., at a Democratic event ahead of a House floor vote on the Health Care and Prescription Drug Package, at the Capitol in Washington, Wednesday, May 15, 2019. (AP Photo/J. Scott Applewhite)
May 16, 2019 - 8:07 pm
WASHINGTON (AP) — Democrats pushed legislation buttressing the 2010 health care law and curbing prescription drug prices through the House Thursday, advancing a bill that has no chance of surviving in the Senate or getting President Donald Trump's signature and seemed engineered with next year's...
Read More
FILE - In this March 13, 2019, file phtooHealth and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington. Azar says drugmakers will soon have to reveal prices of their prescription medicines in those ever-present TV ads. The Trump administration will issue final regulations on May 8 requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. Azar tells The Associated Press if drugmakers are scared to put prices in ads that means they should lower those prices. (AP Photo/Susan Walsh, File)
May 08, 2019 - 10:01 am
WASHINGTON (AP) — Those ever-present TV ads for prescription drugs will soon carry prices, too, the nation's top health official said Wednesday, responding to a public outcry for government action to restrain medication costs. Health and Human Services Secretary Alex Azar said the Trump...
Read More
A report released on Thursday, May 2, 2019, by the Congressional Budget Office is photographed in Washington. Budget experts for Congress say the Trump administration’s plan to reduce out-of-pocket drug costs for Medicare beneficiaries will cost taxpayers another $177 billion from 2020-2029. (AP Photo/Jon Elswick)
May 02, 2019 - 7:49 pm
WASHINGTON (AP) — The Trump administration's plan to ease the financial hit of prescription drugs prices for Medicare beneficiaries will cost taxpayers another $177 billion over 10 years, congressional budget experts said on Thursday. The estimates from the nonpartisan Congressional Budget Office...
Read More

Pages